Protocol for the design and interpretation of method evaluation in atomic absorption spectrometric analysis. Application to the determination of lead and manganese in blood

Abstract

Results of measurements should be independent of the laboratory performing the analysis. Hence the laboratory should document that the method retains statistical control, is without systematic errors and has an acceptably low level of uncertainty. A protocol for the design and interpretation of method evaluation in atomic absorption spectrometry (AAS) using ordinary statistical calculations was applied to determinations of lead and manganese in blood by AAS. The method evaluation design provides information on whether or not the method is in statistical control, i.e., whether the values observed belong to a normal distribution around the mean values. The standard deviation of the normal distribution is an expression of the uncertainty of the method. Using the method evaluation design the estimated uncertainty is truly representative of the methods, i.e., both the withinrun and between-run variations are included. Further, the method evaluation design produces estimates of the magnitude of the systematic error, the limit of detection and the limit of quantification. The application of the mean square error and the square root of the relative mean square error combines the systematic error with the total uncertainty. Hence the square root of the relative mean square error depicts the total analytical error. The systematic error, estimated as the magnitude of the zero point error and the proportional error of the method evaluation functions for Zeeman-effect AAS methods in the determination of manganese, were negligible. The blood lead method was unacceptable at concentrations higher than 200 pg dm-3 owing to the presence of a proportional error. The combined uncertainty of the analytical methods for manganese and lead were 1 .OO and 11.1 pg dm-3, respectively, the limit of detection LODMn=0.2 pg dm-3 and LODpb=12 pg dm-3 at the concentration levels of 11 pg dm-3 of Mn and 72 pg dm+ of Pb. The limit of quantification was LOQMn=2.8 pg dm-3 and LOQpb=33.7 pg dm-3. The design can be conveniently used for quality assurance in AAS analysis and for the characterization of analytical chemical methodology in general.

Metallothionein and Glutathione Content as Biomarkers of Metal Pollution in Mussels and Local Fishermen in Abu Qir Bay, Egypt

“… 14 Mussel gills and digestive glands were rapidly dissected and then stored at 80°C for determination of metals content (Cd, Pb, Cr, Cu, and Zn) in mussels. 15 All digested solutions were analyzed and measured using an atomic absorption spectrophotometer (SPECTR plus version) with an air-acetylene flame and deuterium background correction.…”

Manganese exposure in foundry furnacemen and scrap recycling workers

“…The ratio of observed values to target values was 1.02 (SD 0.057, n 6). Further details of the validation of the method and the quality assurance procedures have been described previously (Christensen et al 1992;Kristiansen et al 1997).…”

Estimation of uncertainties in clinical analysis

“…A high value for uncertainty was obtained by utilization of AAS for Pb and Mn assays in blood [16,17], owing to the low values of analyte concentration. A high value for uncertainty was obtained by utilization of AAS for Pb and Mn assays in blood [16,17], owing to the low values of analyte concentration.…”